Hot topics in infection and immunity in children III:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York, NY
Springer
2006
|
| Schriftenreihe: | Advances in experimental medicine and biology
582 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XXII, 275 S. Ill., graph. Darst. |
| ISBN: | 038731783X 9780387317830 |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV021671331 | ||
| 003 | DE-604 | ||
| 005 | 20070328 | ||
| 007 | t | ||
| 008 | 060725s2006 xxuad|| |||| 10||| eng d | ||
| 020 | |a 038731783X |9 0-387-31783-X | ||
| 020 | |a 9780387317830 |9 978-0-387-31783-0 | ||
| 035 | |a (OCoLC)255371876 | ||
| 035 | |a (DE-599)BVBBV021671331 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-12 |a DE-355 | ||
| 050 | 0 | |a RJ401 | |
| 082 | 0 | |a 618.929 | |
| 084 | |a YD 1824 |0 (DE-625)153284:13153 |2 rvk | ||
| 245 | 1 | 0 | |a Hot topics in infection and immunity in children III |c ed. by Andrew J. Pollard ... |
| 264 | 1 | |a New York, NY |b Springer |c 2006 | |
| 300 | |a XXII, 275 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Advances in experimental medicine and biology |v 582 | |
| 650 | 4 | |a Kind - Infektionskrankheit - Antimikrobieller Wirkstoff - Kongress - Oxford <2005> | |
| 650 | 4 | |a Kind - Infektionskrankheit - Kongress - Oxford <2005> | |
| 650 | 4 | |a Kind | |
| 650 | 4 | |a Bacterial Infections |x drug therapy |x Child | |
| 650 | 4 | |a Bacterial Infections |x immunology |x Child | |
| 650 | 4 | |a Children |x Diseases |x Immunological aspects | |
| 650 | 4 | |a Communicable diseases in children | |
| 650 | 4 | |a Infection in children | |
| 650 | 4 | |a Infection |x drug therapy |x Child | |
| 650 | 4 | |a Infection |x immunology |x Child | |
| 650 | 4 | |a Virus Diseases |x drug therapy |x Child | |
| 650 | 4 | |a Virus Diseases |x immunology |x Child | |
| 650 | 0 | 7 | |a Infektionskrankheit |0 (DE-588)4026879-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Antimikrobieller Wirkstoff |0 (DE-588)4142688-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kind |0 (DE-588)4030550-8 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 2005 |z Oxford |2 gnd-content | |
| 689 | 0 | 0 | |a Kind |0 (DE-588)4030550-8 |D s |
| 689 | 0 | 1 | |a Infektionskrankheit |0 (DE-588)4026879-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Kind |0 (DE-588)4030550-8 |D s |
| 689 | 1 | 1 | |a Infektionskrankheit |0 (DE-588)4026879-2 |D s |
| 689 | 1 | 2 | |a Antimikrobieller Wirkstoff |0 (DE-588)4142688-5 |D s |
| 689 | 1 | |C b |5 DE-604 | |
| 700 | 1 | |a Pollard, Andrew J. |e Sonstige |4 oth | |
| 830 | 0 | |a Advances in experimental medicine and biology |v 582 |w (DE-604)BV000003102 |9 582 | |
| 856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014885690&sequence=000005&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-014885690 | ||
Datensatz im Suchindex
| _version_ | 1804135487594561536 |
|---|---|
| adam_text | Contents
Contributing Authors
1.
Frank Shann
1.
2.
3.
4.
5.
6.
7.
8.
References
2.
Kathryn Maitland
1. Introduction
2.
3.
4.
5.
5.1.
5.2.
5.2.1.
5.3.
6.
6.1.
6.2.
7.
7.1.
7.2.
8.
References
ix
к
3.
of Stigma and Poverty and the Prospects for their Control
and Elimination
Peter Hotez,
and David Molyneux
1.
2.
3.
4.
5.
6.
7.
Acknowledgements
References
4.
Marburg Viruses
Nigel Curtis
1.
2.
2.1.
2.2.
3.
3.1.
3.2.
4.
4.1.
4.2.
5.
5.1.
5.2.
5.3.
6.
7.
8.
9.
9.1.
9.2.
Control Measures
10.
Haemorrhagic Fever
11.
Acknowledgements
References
Contents xi
5.
Roger I. Glass, Joseph Bresee, Baoming Jiang,
Umesh Parashar, Eileen Yee, and
1.
2.
2.1.
the Disease
2.2.
2.3.
2.4.
2.5.
3.
3.1.
3.2.
3.3.
3.4.
4.
4.1.
4.2.
5.
References
6.
the
David A. Randolph and David B. Lewis
1.
2.
2.1.
2.2.
2.3.
3.
in the
4.
4.1.
4.2.
4.3.
5.
References
7.
the Treatment and Prevention of Neonatal Sepsis
Samantha J. Moss and Andrew R. Gennery
1.
2.
Xj¡
2.1.
2.2.
2.3.
2.3.1.
2.3.2.
2.3.2a. The Innate Immune Response
2.3.2b. Immunoglobulin Production and
3.
4.
4.1.
4.2.
5.
5.1.
of Suspected or Proven Neonatal Sepsis
5.2.
the Prevention of Neonatal Sepsis
6.
Acknowledgements
References
8.
and Young Adults
Toni
1.
2.
2.1.
2.2.
3.
3.1.
3.2.
4.
5.
5.1.
5.2.
6.
6.1.
6.2.
6.3.
6.4.
7.
8.
9.
10.
Acknowledgements
References
Contents xiü
9.
of Chronic Lung Disease of Prematurity
Philip L. Davies, Nicola
1.
2.
3.
4.
5.
6.
7.
8.
References
10.
Disease
Tim J. Mitchell
1.
2.
2.1.
2.1.1.
2.1.2.
2.1.3.
2.1.4.
2.2.
2.2.1.
2.2.2.
Serotype 1
2.2.3.
2.3.
3.
References
11.
Bacterial Pneumonia in Children
B. Keith English and Steven C. Buckingham
1.
2.
3.
Pneumonia
3.1.
3.2.
Healthy Children
4.
References
xiv Contents
12.
Hanna Nohynek
1.
2.
3.
in Disease
3.1.
3.2.
3.3.
3.3.1.
3.3.2.
4.
5.
5.1.
Against Them
5.2.
5.3.
Forms of Pneumococcal Disease
5.3.1.
5.3.2.
5.3.3.
5.3.4.
5.3.5.
5.4.
Programs
6.
References
13.
John S. Bradley
1.
2.
3.
4.
4.1.
4.2.
4.3.
4.4.
4.5.
4.6.
4.7.
5.
References
Contents xv
14.
Robert S. Heyderman and Julia Clark
1.
2.
3.
4.
4.1,
4.2.
5.
5.1.
5.2.
5.3.
6.
Acknowledgements
References
15.
Pablo Yagupsky
1.
2.
2.1.
2.2.
3.
4.
4.1.
K. kingae Disease
4.2.
4.3.
4.4.
5.
6.
7.
7.1.
7.2.
8.
References
16.
Nico
1.
2.
3.
4.
xv¡
5.
6.
7.
8.
9.
References
17.
Infants in Africa
Hoosen Coovadia and Derseree Archary
1.
2.
3.
4.
4.1.
4.2.
4.3.
Populations
4.4.
5.
6.
References
18.
Sam Walters
1.
2.
3.
3.1.
3.2.
3.3.
3.4.
3.5.
3.6.
3.7.
3.8.
3.8.1.
3.8.2.
3.8.3.
4.
4.1.
4.2.
Contents xvjj
4.3.
4.3.1.
4.4.
5.
6.
References
19.
Matthew J. Thompson and Paul Glasziou
1.
2.
3.
4.
4.1.
4.2.
4.3.
4.4.
5.
6.
7.
8.
References
20.
Urinary Tract Infections in Children
Elliot Long, Samantha Colquhoun, and Jonathan R. Carapetis
1.
2.
3.
4.
5.
Antibiotic Prophylaxis?
6.
Urinary Tract Infections?
7.
Acknowledgements
References
21.
Respiratory Illness
Adilia Warns and Ronald
1.
2.
3.
xviii Contents
4.
5.
6.
7.
8.
9.
10.
References
Index
Contents
Contributing Authors
1.
Frank Shann
1.
2.
3.
4.
5.
6.
7.
8.
References
2.
Kathryn Maitland
1. Introduction
2.
3.
4.
5.
5.1.
5.2.
5.2.1.
5.3.
6.
6.1.
6.2.
7.
7.1.
7.2.
8.
References
ix
к
3.
of Stigma and Poverty and the Prospects for their Control
and Elimination
Peter Hotez,
and David Molyneux
1.
2.
3.
4.
5.
6.
7.
Acknowledgements
References
4.
Marburg Viruses
Nigel Curtis
1.
2.
2.1.
2.2.
3.
3.1.
3.2.
4.
4.1.
4.2.
5.
5.1.
5.2.
5.3.
6.
7.
8.
9.
9.1.
9.2.
Control Measures
10.
Haemorrhagic Fever
11.
Acknowledgements
References
Contents xi
5.
Roger I. Glass, Joseph Bresee, Baoming Jiang,
Umesh Parashar, Eileen Yee, and
1.
2.
2.1.
the Disease
2.2.
2.3.
2.4.
2.5.
3.
3.1.
3.2.
3.3.
3.4.
4.
4.1.
4.2.
5.
References
6.
the
David A. Randolph and David B. Lewis
1.
2.
2.1.
2.2.
2.3.
3.
in the
4.
4.1.
4.2.
4.3.
5.
References
7.
the Treatment and Prevention of Neonatal Sepsis
Samantha J. Moss and Andrew R. Gennery
1.
2.
Xj¡
2.1.
2.2.
2.3.
2.3.1.
2.3.2.
2.3.2a. The Innate Immune Response
2.3.2b. Immunoglobulin Production and
3.
4.
4.1.
4.2.
5.
5.1.
of Suspected or Proven Neonatal Sepsis
5.2.
the Prevention of Neonatal Sepsis
6.
Acknowledgements
References
8.
and Young Adults
Toni
1.
2.
2.1.
2.2.
3.
3.1.
3.2.
4.
5.
5.1.
5.2.
6.
6.1.
6.2.
6.3.
6.4.
7.
8.
9.
10.
Acknowledgements
References
Contents xiü
9.
of Chronic Lung Disease of Prematurity
Philip L. Davies, Nicola
1.
2.
3.
4.
5.
6.
7.
8.
References
10.
Disease
Tim J. Mitchell
1.
2.
2.1.
2.1.1.
2.1.2.
2.1.3.
2.1.4.
2.2.
2.2.1.
2.2.2.
Serotype 1
2.2.3.
2.3.
3.
References
11.
Bacterial Pneumonia in Children
B. Keith English and Steven C. Buckingham
1.
2.
3.
Pneumonia
3.1.
3.2.
Healthy Children
4.
References
xiv Contents
12.
Hanna Nohynek
1.
2.
3.
in Disease
3.1.
3.2.
3.3.
3.3.1.
3.3.2.
4.
5.
5.1.
Against Them
5.2.
5.3.
Forms of Pneumococcal Disease
5.3.1.
5.3.2.
5.3.3.
5.3.4.
5.3.5.
5.4.
Programs
6.
References
13.
John S. Bradley
1.
2.
3.
4.
4.1.
4.2.
4.3.
4.4.
4.5.
4.6.
4.7.
5.
References
Contents xv
14.
Robert S. Heyderman and Julia Clark
1.
2.
3.
4.
4.1,
4.2.
5.
5.1.
5.2.
5.3.
6.
Acknowledgements
References
15.
Pablo Yagupsky
1.
2.
2.1.
2.2.
3.
4.
4.1.
K. kingae Disease
4.2.
4.3.
4.4.
5.
6.
7.
7.1.
7.2.
8.
References
16.
Nico
1.
2.
3.
4.
xv¡
5.
6.
7.
8.
9.
References
17.
Infants in Africa
Hoosen Coovadia and Derseree Archary
1.
2.
3.
4.
4.1.
4.2.
4.3.
Populations
4.4.
5.
6.
References
18.
Sam Walters
1.
2.
3.
3.1.
3.2.
3.3.
3.4.
3.5.
3.6.
3.7.
3.8.
3.8.1.
3.8.2.
3.8.3.
4.
4.1.
4.2.
Contents xvjj
4.3.
4.3.1.
4.4.
5.
6.
References
19.
Matthew J. Thompson and Paul Glasziou
1.
2.
3.
4.
4.1.
4.2.
4.3.
4.4.
5.
6.
7.
8.
References
20.
Urinary Tract Infections in Children
Elliot Long, Samantha Colquhoun, and Jonathan R. Carapetis
1.
2.
3.
4.
5.
Antibiotic Prophylaxis?
6.
Urinary Tract Infections?
7.
Acknowledgements
References
21.
Respiratory Illness
Adilia Warns and Ronald
1.
2.
3.
xviii Contents
4.
5.
6.
7.
8.
9.
10.
References
Index
|
| adam_txt |
Contents
Contributing Authors
1.
Frank Shann
1.
2.
3.
4.
5.
6.
7.
8.
References
2.
Kathryn Maitland
1. Introduction
2.
3.
4.
5.
5.1.
5.2.
5.2.1.
5.3.
6.
6.1.
6.2.
7.
7.1.
7.2.
8.
References
ix
к
3.
of Stigma and Poverty and the Prospects for their Control
and Elimination
Peter Hotez,
and David Molyneux
1.
2.
3.
4.
5.
6.
7.
Acknowledgements
References
4.
Marburg Viruses
Nigel Curtis
1.
2.
2.1.
2.2.
3.
3.1.
3.2.
4.
4.1.
4.2.
5.
5.1.
5.2.
5.3.
6.
7.
8.
9.
9.1.
9.2.
Control Measures
10.
Haemorrhagic Fever
11.
Acknowledgements
References
Contents xi
5.
Roger I. Glass, Joseph Bresee, Baoming Jiang,
Umesh Parashar, Eileen Yee, and
1.
2.
2.1.
the Disease
2.2.
2.3.
2.4.
2.5.
3.
3.1.
3.2.
3.3.
3.4.
4.
4.1.
4.2.
5.
References
6.
the
David A. Randolph and David B. Lewis
1.
2.
2.1.
2.2.
2.3.
3.
in the
4.
4.1.
4.2.
4.3.
5.
References
7.
the Treatment and Prevention of Neonatal Sepsis
Samantha J. Moss and Andrew R. Gennery
1.
2.
Xj¡
2.1.
2.2.
2.3.
2.3.1.
2.3.2.
2.3.2a. The Innate Immune Response
2.3.2b. Immunoglobulin Production and
3.
4.
4.1.
4.2.
5.
5.1.
of Suspected or Proven Neonatal Sepsis
5.2.
the Prevention of Neonatal Sepsis
6.
Acknowledgements
References
8.
and Young Adults
Toni
1.
2.
2.1.
2.2.
3.
3.1.
3.2.
4.
5.
5.1.
5.2.
6.
6.1.
6.2.
6.3.
6.4.
7.
8.
9.
10.
Acknowledgements
References
Contents xiü
9.
of Chronic Lung Disease of Prematurity
Philip L. Davies, Nicola
1.
2.
3.
4.
5.
6.
7.
8.
References
10.
Disease
Tim J. Mitchell
1.
2.
2.1.
2.1.1.
2.1.2.
2.1.3.
2.1.4.
2.2.
2.2.1.
2.2.2.
Serotype 1
2.2.3.
2.3.
3.
References
11.
Bacterial Pneumonia in Children
B. Keith English and Steven C. Buckingham
1.
2.
3.
Pneumonia
3.1.
3.2.
Healthy Children
4.
References
xiv Contents
12.
Hanna Nohynek
1.
2.
3.
in Disease
3.1.
3.2.
3.3.
3.3.1.
3.3.2.
4.
5.
5.1.
Against Them
5.2.
5.3.
Forms of Pneumococcal Disease
5.3.1.
5.3.2.
5.3.3.
5.3.4.
5.3.5.
5.4.
Programs
6.
References
13.
John S. Bradley
1.
2.
3.
4.
4.1.
4.2.
4.3.
4.4.
4.5.
4.6.
4.7.
5.
References
Contents xv
14.
Robert S. Heyderman and Julia Clark
1.
2.
3.
4.
4.1,
4.2.
5.
5.1.
5.2.
5.3.
6.
Acknowledgements
References
15.
Pablo Yagupsky
1.
2.
2.1.
2.2.
3.
4.
4.1.
K. kingae Disease
4.2.
4.3.
4.4.
5.
6.
7.
7.1.
7.2.
8.
References
16.
Nico
1.
2.
3.
4.
xv¡
5.
6.
7.
8.
9.
References
17.
Infants in Africa
Hoosen Coovadia and Derseree Archary
1.
2.
3.
4.
4.1.
4.2.
4.3.
Populations
4.4.
5.
6.
References
18.
Sam Walters
1.
2.
3.
3.1.
3.2.
3.3.
3.4.
3.5.
3.6.
3.7.
3.8.
3.8.1.
3.8.2.
3.8.3.
4.
4.1.
4.2.
Contents xvjj
4.3.
4.3.1.
4.4.
5.
6.
References
19.
Matthew J. Thompson and Paul Glasziou
1.
2.
3.
4.
4.1.
4.2.
4.3.
4.4.
5.
6.
7.
8.
References
20.
Urinary Tract Infections in Children
Elliot Long, Samantha Colquhoun, and Jonathan R. Carapetis
1.
2.
3.
4.
5.
Antibiotic Prophylaxis?
6.
Urinary Tract Infections?
7.
Acknowledgements
References
21.
Respiratory Illness
Adilia Warns and Ronald
1.
2.
3.
xviii Contents
4.
5.
6.
7.
8.
9.
10.
References
Index
Contents
Contributing Authors
1.
Frank Shann
1.
2.
3.
4.
5.
6.
7.
8.
References
2.
Kathryn Maitland
1. Introduction
2.
3.
4.
5.
5.1.
5.2.
5.2.1.
5.3.
6.
6.1.
6.2.
7.
7.1.
7.2.
8.
References
ix
к
3.
of Stigma and Poverty and the Prospects for their Control
and Elimination
Peter Hotez,
and David Molyneux
1.
2.
3.
4.
5.
6.
7.
Acknowledgements
References
4.
Marburg Viruses
Nigel Curtis
1.
2.
2.1.
2.2.
3.
3.1.
3.2.
4.
4.1.
4.2.
5.
5.1.
5.2.
5.3.
6.
7.
8.
9.
9.1.
9.2.
Control Measures
10.
Haemorrhagic Fever
11.
Acknowledgements
References
Contents xi
5.
Roger I. Glass, Joseph Bresee, Baoming Jiang,
Umesh Parashar, Eileen Yee, and
1.
2.
2.1.
the Disease
2.2.
2.3.
2.4.
2.5.
3.
3.1.
3.2.
3.3.
3.4.
4.
4.1.
4.2.
5.
References
6.
the
David A. Randolph and David B. Lewis
1.
2.
2.1.
2.2.
2.3.
3.
in the
4.
4.1.
4.2.
4.3.
5.
References
7.
the Treatment and Prevention of Neonatal Sepsis
Samantha J. Moss and Andrew R. Gennery
1.
2.
Xj¡
2.1.
2.2.
2.3.
2.3.1.
2.3.2.
2.3.2a. The Innate Immune Response
2.3.2b. Immunoglobulin Production and
3.
4.
4.1.
4.2.
5.
5.1.
of Suspected or Proven Neonatal Sepsis
5.2.
the Prevention of Neonatal Sepsis
6.
Acknowledgements
References
8.
and Young Adults
Toni
1.
2.
2.1.
2.2.
3.
3.1.
3.2.
4.
5.
5.1.
5.2.
6.
6.1.
6.2.
6.3.
6.4.
7.
8.
9.
10.
Acknowledgements
References
Contents xiü
9.
of Chronic Lung Disease of Prematurity
Philip L. Davies, Nicola
1.
2.
3.
4.
5.
6.
7.
8.
References
10.
Disease
Tim J. Mitchell
1.
2.
2.1.
2.1.1.
2.1.2.
2.1.3.
2.1.4.
2.2.
2.2.1.
2.2.2.
Serotype 1
2.2.3.
2.3.
3.
References
11.
Bacterial Pneumonia in Children
B. Keith English and Steven C. Buckingham
1.
2.
3.
Pneumonia
3.1.
3.2.
Healthy Children
4.
References
xiv Contents
12.
Hanna Nohynek
1.
2.
3.
in Disease
3.1.
3.2.
3.3.
3.3.1.
3.3.2.
4.
5.
5.1.
Against Them
5.2.
5.3.
Forms of Pneumococcal Disease
5.3.1.
5.3.2.
5.3.3.
5.3.4.
5.3.5.
5.4.
Programs
6.
References
13.
John S. Bradley
1.
2.
3.
4.
4.1.
4.2.
4.3.
4.4.
4.5.
4.6.
4.7.
5.
References
Contents xv
14.
Robert S. Heyderman and Julia Clark
1.
2.
3.
4.
4.1,
4.2.
5.
5.1.
5.2.
5.3.
6.
Acknowledgements
References
15.
Pablo Yagupsky
1.
2.
2.1.
2.2.
3.
4.
4.1.
K. kingae Disease
4.2.
4.3.
4.4.
5.
6.
7.
7.1.
7.2.
8.
References
16.
Nico
1.
2.
3.
4.
xv¡
5.
6.
7.
8.
9.
References
17.
Infants in Africa
Hoosen Coovadia and Derseree Archary
1.
2.
3.
4.
4.1.
4.2.
4.3.
Populations
4.4.
5.
6.
References
18.
Sam Walters
1.
2.
3.
3.1.
3.2.
3.3.
3.4.
3.5.
3.6.
3.7.
3.8.
3.8.1.
3.8.2.
3.8.3.
4.
4.1.
4.2.
Contents xvjj
4.3.
4.3.1.
4.4.
5.
6.
References
19.
Matthew J. Thompson and Paul Glasziou
1.
2.
3.
4.
4.1.
4.2.
4.3.
4.4.
5.
6.
7.
8.
References
20.
Urinary Tract Infections in Children
Elliot Long, Samantha Colquhoun, and Jonathan R. Carapetis
1.
2.
3.
4.
5.
Antibiotic Prophylaxis?
6.
Urinary Tract Infections?
7.
Acknowledgements
References
21.
Respiratory Illness
Adilia Warns and Ronald
1.
2.
3.
xviii Contents
4.
5.
6.
7.
8.
9.
10.
References
Index |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| building | Verbundindex |
| bvnumber | BV021671331 |
| callnumber-first | R - Medicine |
| callnumber-label | RJ401 |
| callnumber-raw | RJ401 |
| callnumber-search | RJ401 |
| callnumber-sort | RJ 3401 |
| callnumber-subject | RJ - Pediatrics |
| classification_rvk | YD 1824 |
| ctrlnum | (OCoLC)255371876 (DE-599)BVBBV021671331 |
| dewey-full | 618.929 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 618 - Gynecology, obstetrics, pediatrics, geriatrics |
| dewey-raw | 618.929 |
| dewey-search | 618.929 |
| dewey-sort | 3618.929 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02579nam a2200625zcb4500</leader><controlfield tag="001">BV021671331</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20070328 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">060725s2006 xxuad|| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">038731783X</subfield><subfield code="9">0-387-31783-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780387317830</subfield><subfield code="9">978-0-387-31783-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)255371876</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV021671331</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RJ401</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">618.929</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YD 1824</subfield><subfield code="0">(DE-625)153284:13153</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Hot topics in infection and immunity in children III</subfield><subfield code="c">ed. by Andrew J. Pollard ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Springer</subfield><subfield code="c">2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXII, 275 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Advances in experimental medicine and biology</subfield><subfield code="v">582</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Kind - Infektionskrankheit - Antimikrobieller Wirkstoff - Kongress - Oxford <2005></subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Kind - Infektionskrankheit - Kongress - Oxford <2005></subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Kind</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bacterial Infections</subfield><subfield code="x">drug therapy</subfield><subfield code="x">Child</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bacterial Infections</subfield><subfield code="x">immunology</subfield><subfield code="x">Child</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Children</subfield><subfield code="x">Diseases</subfield><subfield code="x">Immunological aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Communicable diseases in children</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infection in children</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infection</subfield><subfield code="x">drug therapy</subfield><subfield code="x">Child</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infection</subfield><subfield code="x">immunology</subfield><subfield code="x">Child</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Virus Diseases</subfield><subfield code="x">drug therapy</subfield><subfield code="x">Child</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Virus Diseases</subfield><subfield code="x">immunology</subfield><subfield code="x">Child</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Infektionskrankheit</subfield><subfield code="0">(DE-588)4026879-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antimikrobieller Wirkstoff</subfield><subfield code="0">(DE-588)4142688-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kind</subfield><subfield code="0">(DE-588)4030550-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">2005</subfield><subfield code="z">Oxford</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Kind</subfield><subfield code="0">(DE-588)4030550-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Infektionskrankheit</subfield><subfield code="0">(DE-588)4026879-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Kind</subfield><subfield code="0">(DE-588)4030550-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Infektionskrankheit</subfield><subfield code="0">(DE-588)4026879-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Antimikrobieller Wirkstoff</subfield><subfield code="0">(DE-588)4142688-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pollard, Andrew J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Advances in experimental medicine and biology</subfield><subfield code="v">582</subfield><subfield code="w">(DE-604)BV000003102</subfield><subfield code="9">582</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014885690&sequence=000005&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-014885690</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 2005 Oxford gnd-content |
| genre_facet | Konferenzschrift 2005 Oxford |
| id | DE-604.BV021671331 |
| illustrated | Illustrated |
| index_date | 2024-07-02T15:08:53Z |
| indexdate | 2024-07-09T20:41:17Z |
| institution | BVB |
| isbn | 038731783X 9780387317830 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-014885690 |
| oclc_num | 255371876 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR |
| owner_facet | DE-12 DE-355 DE-BY-UBR |
| physical | XXII, 275 S. Ill., graph. Darst. |
| publishDate | 2006 |
| publishDateSearch | 2006 |
| publishDateSort | 2006 |
| publisher | Springer |
| record_format | marc |
| series | Advances in experimental medicine and biology |
| series2 | Advances in experimental medicine and biology |
| spelling | Hot topics in infection and immunity in children III ed. by Andrew J. Pollard ... New York, NY Springer 2006 XXII, 275 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Advances in experimental medicine and biology 582 Kind - Infektionskrankheit - Antimikrobieller Wirkstoff - Kongress - Oxford <2005> Kind - Infektionskrankheit - Kongress - Oxford <2005> Kind Bacterial Infections drug therapy Child Bacterial Infections immunology Child Children Diseases Immunological aspects Communicable diseases in children Infection in children Infection drug therapy Child Infection immunology Child Virus Diseases drug therapy Child Virus Diseases immunology Child Infektionskrankheit (DE-588)4026879-2 gnd rswk-swf Antimikrobieller Wirkstoff (DE-588)4142688-5 gnd rswk-swf Kind (DE-588)4030550-8 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 2005 Oxford gnd-content Kind (DE-588)4030550-8 s Infektionskrankheit (DE-588)4026879-2 s DE-604 Antimikrobieller Wirkstoff (DE-588)4142688-5 s b DE-604 Pollard, Andrew J. Sonstige oth Advances in experimental medicine and biology 582 (DE-604)BV000003102 582 Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014885690&sequence=000005&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Hot topics in infection and immunity in children III Advances in experimental medicine and biology Kind - Infektionskrankheit - Antimikrobieller Wirkstoff - Kongress - Oxford <2005> Kind - Infektionskrankheit - Kongress - Oxford <2005> Kind Bacterial Infections drug therapy Child Bacterial Infections immunology Child Children Diseases Immunological aspects Communicable diseases in children Infection in children Infection drug therapy Child Infection immunology Child Virus Diseases drug therapy Child Virus Diseases immunology Child Infektionskrankheit (DE-588)4026879-2 gnd Antimikrobieller Wirkstoff (DE-588)4142688-5 gnd Kind (DE-588)4030550-8 gnd |
| subject_GND | (DE-588)4026879-2 (DE-588)4142688-5 (DE-588)4030550-8 (DE-588)1071861417 |
| title | Hot topics in infection and immunity in children III |
| title_auth | Hot topics in infection and immunity in children III |
| title_exact_search | Hot topics in infection and immunity in children III |
| title_exact_search_txtP | Hot topics in infection and immunity in children III |
| title_full | Hot topics in infection and immunity in children III ed. by Andrew J. Pollard ... |
| title_fullStr | Hot topics in infection and immunity in children III ed. by Andrew J. Pollard ... |
| title_full_unstemmed | Hot topics in infection and immunity in children III ed. by Andrew J. Pollard ... |
| title_short | Hot topics in infection and immunity in children III |
| title_sort | hot topics in infection and immunity in children iii |
| topic | Kind - Infektionskrankheit - Antimikrobieller Wirkstoff - Kongress - Oxford <2005> Kind - Infektionskrankheit - Kongress - Oxford <2005> Kind Bacterial Infections drug therapy Child Bacterial Infections immunology Child Children Diseases Immunological aspects Communicable diseases in children Infection in children Infection drug therapy Child Infection immunology Child Virus Diseases drug therapy Child Virus Diseases immunology Child Infektionskrankheit (DE-588)4026879-2 gnd Antimikrobieller Wirkstoff (DE-588)4142688-5 gnd Kind (DE-588)4030550-8 gnd |
| topic_facet | Kind - Infektionskrankheit - Antimikrobieller Wirkstoff - Kongress - Oxford <2005> Kind - Infektionskrankheit - Kongress - Oxford <2005> Kind Bacterial Infections drug therapy Child Bacterial Infections immunology Child Children Diseases Immunological aspects Communicable diseases in children Infection in children Infection drug therapy Child Infection immunology Child Virus Diseases drug therapy Child Virus Diseases immunology Child Infektionskrankheit Antimikrobieller Wirkstoff Konferenzschrift 2005 Oxford |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014885690&sequence=000005&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000003102 |
| work_keys_str_mv | AT pollardandrewj hottopicsininfectionandimmunityinchildreniii |